10 healthcare stocks post over 10% sales & profit growth in June quarter; rally in FY26
1/12
In Good Health
In the healthcare sector, around 15 companies have reported over 10% year-on-year growth in both sales and net profit for the June quarter. The analysis includes only those stocks with a market capitalization above Rs 3,000 crore, ensuring focus on larger, more established players.
Among these, 10 stocks have delivered double-digit price returns so far in FY26, reflecting strong investor confidence and positive market performance. However, it's worth noting that 3 stocks from the same group have posted negative returns during the same period. (Data Source: ACE Equity)
Among these, 10 stocks have delivered double-digit price returns so far in FY26, reflecting strong investor confidence and positive market performance. However, it's worth noting that 3 stocks from the same group have posted negative returns during the same period. (Data Source: ACE Equity)
2/12
Thyrocare Technologies
In the June quarter, the company reported a 23% increase in revenue to Rs 193 crore and a 57% rise in net profit to Rs 38 crore. The stock has delivered a 94% return so far in FY26, reaching Rs 1,319.
3/12
Yatharth Hospital & Trauma Care Services
The company posted 22% revenue growth to Rs 258 crore and a 38% increase in profit to Rs 42 crore. Its stock has surged 61% in FY26, now trading at Rs 685.
Amazon Top Deals
POWERED BY
Crompton Ozone 75 Litres Desert Air Cooler for home | Large & Easy Clean Ice Chamber | 4-Way Air Deflection | High Density Honeycomb Pads | Everlast Pump | Auto Fill| 3 Year Brand Warranty
₹9,798Buy Now43%
OFF
LG 32 L Convection Microwave Oven (MC3286BRUM, Black, 360° Motorised Rotisserie for Bar-be-queing, 301 Auto Cook Menu, Stainless steel cavity, Indian Cuisine, Tandoor Se, Steam Clean & Diet Fry)
₹18,780Buy Now22%
OFF
4/12
Laurus Labs
Revenue rose 31% to Rs 1,570 crore, while profit soared 1,219% to Rs 161 crore. The stock has gained 40% in FY26, currently at Rs 857.
5/12
Dr. Lal Pathlabs
The company saw an 11% rise in revenue to Rs 670 crore and a 24% increase in profit to Rs 134 crore. Its stock has appreciated 29% in FY26 to Rs 3,192.
6/12
Procter & Gamble Health
Sales grew 19% to Rs 339 crore, and net profit jumped 294% to Rs 66 crore. The stock has gained 20% so far in FY26, now priced at Rs 6,186.
7/12
Senores Pharmaceuticals
In Q1, revenue rose 64% to Rs 130 crore and profit increased 94% to Rs 21 crore. The stock has climbed 18% in FY26, trading at Rs 676.
8/12
Advanced Enzyme Technologies
The company recorded a 20% increase in sales to Rs 186 crore and a 16% profit growth to Rs 40 crore. The stock is up 15% in FY26, at Rs 321.
9/12
Divi's Laboratories
Sales rose 14% to Rs 2,410 crore, while profit improved 27% to Rs 545 crore. The stock has advanced 11% so far in FY26, now at Rs 6,409.
10/12
Torrent Pharmaceuticals
The company reported an 11% increase in sales to Rs 3,128 crore and a 20% rise in profit to Rs 548 crore. The stock has gained 11% in FY26, reaching Rs 3,589.
11/12
Acutaas Chemicals
Revenue grew 17% to Rs 207 crore and profit surged 200% to Rs 44 crore. The stock is up 10% in FY26, trading at Rs 1,342.
12/12
Sanofi Consumer Healthcare India
In the June quarter, sales grew 28% to Rs 221 crore and profit rose 109% to Rs 61 crore. The stock has increased 9% in FY26 so far, now priced at Rs 5,276.